LIFE 8-K Filed 2026-08-03 New authorization

Ethos authorizes $100M share repurchase program

Life insurance tech firm greenlights stock buyback amid 113% Q2 revenue growth and profitability.

Authorization$100M
MechanismNot specified

What the filing says

Ethos Technologies Inc. (Nasdaq: LIFE) announced that its Board of Directors has authorized a share repurchase program of up to $100 million of the Company's outstanding Class A common stock. The authorization was disclosed in an earnings announcement filed as an 8-K on August 3, 2026, concurrent with the release of second quarter fiscal 2026 financial results.

The repurchase program comes as the company reports robust operational performance, with Q2 revenue growing 113% year-over-year to $189.6 million, driven by 131% growth in direct channel revenue ($116.5 million) and 90% growth in third-party channel revenue ($73.1 million). Net income for the quarter reached $19.5 million, representing a 10% net margin, while adjusted EBITDA was $35.2 million with a 19% margin.

The filing does not specify the execution mechanism (Rule 10b-18 open-market purchases, accelerated share repurchase, or other method), the duration of the authorization, or whether a 10b5-1 trading plan has been established. No execution details, share count targets, or average repurchase prices are disclosed in this announcement.

Ethos announced today that its Board of Directors has authorized a share repurchase program of up to $100 million of the Company's outstanding Class A common stock. — Ethos Technologies Inc. 8-K filing  ·  View on SEC EDGAR →

What this means

The $100 million authorization represents a capital allocation decision by Ethos' Board, signaling confidence in the company's financial position and future prospects. At Q2 net income run rate (annualized ~$78 million) and current cash position ($112.2 million in cash and equivalents, plus $140.7 million in short- and long-term investments), the buyback is modest relative to the company's liquidity and profitability. The authorization does not obligate the company to repurchase any shares; timing, execution method, and actual repurchase amount remain at management's discretion. Share-count impact will depend on execution timing and market prices at repurchase.

Frequently asked questions

What is the size and scope of Ethos' new share repurchase program?
The Board has authorized a buyback program of up to $100 million of the company's Class A common stock. The authorization does not specify a time limit, execution mechanism, or target share count—those details remain at management's discretion subject to market conditions and strategic priorities.
When might Ethos begin repurchasing shares under this authorization?
The filing does not disclose timing, execution method (open-market, ASR, 10b5-1 plan, etc.), or whether repurchases have already begun. Investors should monitor Form 4 filings, 10-Q disclosures, and earnings announcements for execution details and share-count updates.
How does this authorization fit with Ethos' financial position and growth?
Ethos reported $112.2 million in cash and $140.7 million in investments as of June 30, 2026, alongside 113% year-over-year revenue growth and positive net income. The $100 million authorization is modest relative to the company's liquidity and profitability, suggesting management is not constrained by cash availability for other strategic investments or obligations.
Does this authorization commit Ethos to repurchase any shares?
No. A board authorization grants management the right (but not an obligation) to repurchase shares up to the specified dollar amount. Execution remains discretionary and subject to market conditions, regulatory considerations, and other business priorities.
How is this announcement relevant to share-count and EPS?
If executed, the repurchase will reduce the weighted-average share count outstanding, which can support or inflate EPS on a per-share basis independent of earnings growth. The impact depends on the price at which shares are repurchased relative to intrinsic value and the company's cost of capital.
Will Ethos disclose repurchase activity after it occurs?
Yes. Public companies must disclose share repurchases in quarterly 10-Q filings, annual 10-K reports, and sometimes in Item 5 of Form 10-Q under the heading 'Issuer Purchases of Equity Securities.' Investors can also track open-market repurchases via SEC EDGAR filings and company investor relations disclosures.
authorization fintech life-insurance high-growth post-ipo
Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.